C34 PEG 4 Chol

Drug Profile

C34 PEG 4 Chol

Alternative Names: C34 polyethylene glycol 4 cholesterol; HIVP 3; Peptivir-H

Latest Information Update: 17 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PeptiPharma
  • Developer Imperial College of Science, Technology and Medicine
  • Class Antivirals; Lipids; Polyethylene glycols
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I HIV infections

Most Recent Events

  • 15 Feb 2015 Phase-I clinical trials in HIV infections in United Kingdom (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top